![]() |
市場調查報告書
商品編碼
1264993
皮下注射器和針頭市場——按類型、敏感性、應用、最終用途和預測,2023-2032 年Hypodermic Syringes & Needles Market - By Type, By Usability, By Application, By End-use & Forecast, 2023 - 2032 |
由於慢性病激增,全球皮下注射器和針頭市場預計到 2032 年將出現顯著增長。
根據紐約州衛生部的數據,心髒病每年在美國造成約 697,000 人死亡,佔死亡人數的五分之一。 不斷增加的疾病負擔正在增加手術的數量,進一步增加了對皮下注射器和針頭的需求。
皮下注射器和針頭市場按類型、可用□□性、應用、最終用途和地區劃分。
基於易用性,由於市場參與者對新產品創新的不斷努力,預計到 2032 年可重複使用部分皮下注射器和針頭行業將實現可觀的利潤。 此外,可重複使用的皮下注射器和針頭適用於注射抗生素和疫苗。 此外,政府部門對大規模疫苗接種的投資顯著增加,也可能進一步推動該行業的增長。
從應用的角度來看,隨著政府當局越來越關注公共安全的疫苗接種,疫苗接種領域的皮下注射器和針頭行業將從 2023 年到 2032 年實現顯著的複合年增長率。預計將在 事實上,2022 年 1 月,阿根廷發起了針對 COVID-19 的全國疫苗接種運動,以恢復學校的面對面授課。 同樣,新興經濟體政府加大力度抗擊傳染病,預計將為市場擴張鋪平道路。
到 2032 年,診斷中心皮下注射器和針頭市場的最終用途預計估值將超過 20 億美元。 微創外科手術的普及顯著增加,例如用於組織樣本病理分析的核心針活檢,增加了診斷中心對皮下注射器和針頭的需求。 此外,這些儀器可以通過精確定位手術部位來獲取組織樣本,從而減少術後並發症並加快恢復速度。
按地區劃分,從 2023 年到 2032 年,亞太地區的皮下注射器和針頭行業預計將以超過 4.5% 的複合年增長率增長。 易患疾病的老年人口越來越多,就診頻率也越來越高,對我們的產品產生了強勁的需求。 據世界衛生組織稱,到 2040 年,中國 28% 的人口,即 4.02 億人,將超過 60 歲。
Global Hypodermic Syringes & Needles Market is anticipated to register remarkable gains through 2032 on account of the surging prevalence of chronic disorders. As per the New York State Department of Health, in the U.S., heart disease causes around 697,000 deaths every year, which accounts for 1 in every 5 deaths. The growing disease burden has increased the number of surgeries, further escalating the need for hypodermic syringes & needles.
Overall, the hypodermic syringes & needles market is segmented in terms of type, usability, application, end-use, and region.
Based on usability, the hypodermic syringes & needles industry from the reusable segment is slated to register considerable gains through 2032, owing to the growing efforts of market players on new product innovations. Moreover, hypodermic reusable syringes and needles work well for the administration of injectable antibiotics and vaccines. In addition, a commendable rise in investments by government authorities in mega vaccination drives may further bolster segment growth.
In terms of application, the hypodermic syringes & needles industry from the vaccination segment is expected to grow at a substantial CAGR from 2023 to 2032, owing to the growing focus of government authorities on vaccination drives for public safety. In fact, in January 2022, Argentina implemented a National Vaccination Campaign in an effort to combat COVID-19 to restore in-person classes in schools. Likewise, the growing efforts of governments of developing economies to fight against infectious diseases are likely to pave the way for market expansion.
With respect to end-use, the hypodermic syringes & needles market from the diagnostic centers segment is slated to record a valuation of over USD 2 billion by 2032. A remarkable rise in the popularity of minimally invasive surgical procedures, such as core needle biopsy for pathological analysis of tissue samples, has bolstered the need for hypodermic syringes & needles in diagnostic centers. Moreover, these devices help obtain tissue samples by precisely targeting the area to be operated, leading to fewer postoperative complications and quick recovery.
From the regional perspective, the Asia Pacific hypodermic syringes & needles industry is poised to grow at over 4.5% CAGR from 2023 to 2032. The rising geriatric population, which is highly susceptible to diseases, has increased the frequency of visits to medical facilities, creating a strong demand for the product. As per WHO, an estimated 402 million people, which makes up 28% of the population in China will be over the age of 60 years by 2040.